The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy
Abstract
Alendronate, an inhibitor of bone resorption, is widely used in osteoporosis treatment. However, concerns have been raised about potential oversuppression of bone turnover during long-term use. We report on nine patients who sustained spontaneous nonspinal fractures while on alendronate therapy, six of whom displayed either delayed or absent fracture healing for 3 months to 2 yr during therapy. Histomorphometric analysis of the cancellous bone showed markedly suppressed bone formation, with reduced or absent osteoblastic surface in most patients. Osteoclastic surface was low or low-normal in eight patients, and eroded surface was decreased in four. Matrix synthesis was markedly diminished, with absence of double-tetracycline label and absent or reduced single-tetracycline label in all patients. The same trend was seen in the intracortical and endocortical surfaces. Our findings raise the possibility that severe suppression of bone turnover may develop during long-term alendronate therapy, resulting in increased susceptibility to, and delayed healing of, nonspinal fractures. Although coadministration of estrogen or glucocorticoids appears to be a predisposing factor, this apparent complication can also occur with monotherapy. Our observations emphasize the need for increased awareness and monitoring for the potential development of excessive suppression of bone turnover during long-term alendronate therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
Ruggiero, S. L., Mehrotra, B., Rosenberg, T. J., & Engroff, S. L. (2004) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2004.02.004 · Cited by 2,057
Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women
Bone, H. G., Hosking, D., Devogelaer, J.-P., Tucci, J. R., Emkey, R. D., Tonino, R. P., Rodriguez-Portales, J. A., Downs, R. W., Gupta, J., Santora, A. C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030897 · Cited by 1,347
Bisphosphonates: Mechanisms of Action
Fleisch, H. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0325 · Cited by 1,019
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
Black, D. M., Thompson, D. E., Bauer, D. C., Ensrud, K., Musliner, T., Hochberg, M. C., Nevitt, M. C., Suryawanshi, S., & Cummings, S. R. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6953 · Cited by 982
Alendronate for the Treatment of Osteoporosis in Men
Orwoll, E., Ettinger, M., Weiss, S., Miller, P., Kendler, D., Graham, J., Adami, S., Weber, K., Lorenc, R., Pietschmann, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008313430902 · Cited by 973
Garnero, P. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1693 · Cited by 707
Mashiba, T., Hirano, T., Turner, C. H., Forwood, M. R., Johnston, C. C., & Burr, D. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.613 · Cited by 688
Chavassieux, P. M., Arlot, M. E., Reda, C., Wei, L., Yates, A. J., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523
Mashiba, T., Turner, C. H., Hirano, T., Forwood, M. R., Johnston, C. C., & Burr, D. B. (2001) · Bone · doi:10.1016/s8756-3282(01)00414-8 · Cited by 484
Bisphosphonate-Induced Osteopetrosis
Whyte, M. P., Wenkert, D., Clements, K. L., McAlister, W. H., & Mumm, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa023110 · Cited by 446
Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women1
Tonino, R. P., Meunier, P. J., Emkey, R., Rodriguez-Portales, J. A., Menkes, C.-J., Wasnich, R. D., Bone, H. G., Santora, A. C., Wu, M., Desai, R., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6777 · Cited by 335
Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females
Dr. Recker, R. R., Kimmel, D. B., Parfitt, M. A., Davies, M. K., Keshawarz, N., & Hinders, S. (1988) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650030203 · Cited by 277
Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density
Bone, H. G. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.720 · Cited by 277
Aging of Microstructural Compartments in Human Compact Bone
Akkus, O., Polyakova-Akkus, A., Adar, F., & Schaffler, M. B. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.6.1012 · Cited by 263
Han, Z.-H., Palnitkar, S., Rao, D. S., Nelson, D., & Parfitt, A. M. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.4.498 · Cited by 252
Self-citationSkeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women
Tonino, R. P. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3109 · Cited by 188
Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
Black, D. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4118 · Cited by 187
Harris, S. T. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.6.1399 · Cited by 182
Lindsay, R., Cosman, F., Lobo, R. A., Walsh, B. W., Harris, S. T., Reagan, J. E., Liss, C. L., Melton, M. E., & Byrnes, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5989 · Cited by 180
Changes in Bone Remodeling Rate Influence the Degree of Mineralization of Bone
Boivin, G., & Meunier, P. J. (2002) · Connective Tissue Research · doi:10.1080/03008200290000934 · Cited by 176
Li, J., Mashiba, T., & Burr, D. B. (2001) · Calcified Tissue International · doi:10.1007/s002230010036 · Cited by 176
Ciarelli, T. E., Fyhrie, D. P., & PARFITT, A. M. (2003) · Bone · doi:10.1016/s8756-3282(02)00975-4 · Cited by 142
Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry
PARFITT, A. M. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200307000-00007 · Cited by 135
Changes in Bone Mass and Bone Turnover Following Distal Forearm Fracture
Ingle, B. M., Hay, S. M., Bottjer, H. M., & Eastell, R. (1999) · Osteoporosis International · doi:10.1007/s001980050246 · Cited by 128
Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation?
Hirano, T., Turner, C. H., Forwood, M. R., Johnston, C. C., & Burr, D. B. (2000) · Bone · doi:10.1016/s8756-3282(00)00284-2 · Cited by 114
PARFITT, A. M., Han, Z.-H., Palnitkar, S., Rao, D. S., Shih, M. S., & Nelson, D. A. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1864 · Cited by 113
Self-citationBagger, Y. Z., Tankó, L. B., Alexandersen, P., Ravn, P., & Christiansen, C. (2003) · Bone · doi:10.1016/s8756-3282(03)00112-1 · Cited by 108
Lindsay, R. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3076 · Cited by 97
Foldes, J., Shih, M., & PARFITT, A. M. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051010 · Cited by 96
Fractures after Long-Term Alendronate Therapy
Ott, S. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7436-1 · Cited by 53
Alendronate for the Treatment of Osteoporosis in Men
Adámi, S., Prizzi, R., & Colapietro, F. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-1066-2 · Cited by 32
Histomorphometric features of bone in patients with primary and secondary hypoparathyroidism
Ubara, Y., Fushimi, T., Tagami, T., Sawa, N., Hoshino, J., Yokota, M., Katori, H., Takemoto, F., & Hara, S. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00916.x · Cited by 30
Ten years’ experience with alendronate for osteoporosis in postmenopausal women*
(2004) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000132849.06696.4b · Cited by 30
&NA; (1996) · The Endocrinologist · doi:10.1097/00019616-199605000-00025 · Cited by 19
Zerwekh, J. E., Antich, P. P., Sakhaee, K., Prior, J. O., Gonzales, J., Gottschalk, F., & Pak, C. Y. C. (1992) · Bone and Mineral · doi:10.1016/0169-6009(92)90800-s · Cited by 17
Self-citationSafety of Long-Term Alendronate
Tonino, R. P. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1835-a · Cited by 8
Cited by
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Seeman, E., & Delmas, P. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra053077 · Cited by 2,080
Bisphosphonates: Mechanism of action and role in clinical practice
Drake, M. T., Clarke, B. L., & Khosla, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1032 · Cited by 1,644
Russell, R. G. G., Watts, N. B., Ebetino, F. H., & Rogers, M. J. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0540-8 · Cited by 1,411
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Woo, S.-B., Hellstein, J. W., & Kalmar, J. R. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00009 · Cited by 1,252
Metadata
- Authors
- Odvina, C. V., Zerwekh, J. E., Rao, D. S., Maalouf, N., Gottschalk, F. A., & Pak, C. Y. C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-03
- Volume
- 90
- Issue
- 3
- Pages
- 1294-1301
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022094899
- Cited by
- 1,432
- References
- 38
- FWCI
- 70.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.